We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
MKS Inc
MKSI
$20.7B
| $1.87M | 0.01% |
17,900
-200
| -1% | -$21.6K |
|
702
Robert Half
RHI
$4.48B
| $1.87M | 0.01% |
26,500
| – | – |
|
703
Bio-Rad Laboratories Class A
BIO
$9.66B
| $1.86M | 0.01% |
5,672
+400
| +8% | +$136K |
|
704
ESAB
ESAB
$5.29B
| $1.86M | 0.01% |
15,500
+1,100
| +8% | +$133K |
|
705
Dropbox
DBX
$7.81B
| $1.86M | 0.01% |
61,800
+6,900
| +13% | +$191K |
|
|
SNV
706
DELISTED
Synovus
SNV
| $1.85M | 0.01% |
36,172
-1,200
| -3% | -$62.2K |
|
707
STAG Industrial
STAG
$7.12B
| $1.85M | 0.01% |
54,802
+4,500
| +9% | +$165K |
|
708
Genpact
G
$5.78B
| $1.85M | 0.01% |
43,000
+4,900
| +13% | +$207K |
|
709
Old National Bancorp
ONB
$10.4B
| $1.85M | 0.01% |
85,059
+8,400
| +11% | +$175K |
|
710
Fidelity National Financial
FNF
$13.1B
| $1.84M | 0.01% |
32,739
+12,135
| +59% | +$731K |
|
711
Etsy
ETSY
$7.4B
| $1.83M | 0.01% |
34,699
+6,260
| +22% | +$334K |
|
|
SMAR
712
DELISTED
Smartsheet Inc.
SMAR
| $1.81M | 0.01% |
32,275
+2,300
| +8% | +$129K |
|
713
Coca-Cola Consolidated
COKE
$12.7B
| $1.81M | 0.01% |
14,330
| – | – |
|
714
Vornado Realty Trust
VNO
$7.41B
| $1.79M | 0.01% |
42,500
| – | – |
|
|
BECN
715
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $1.78M | 0.01% |
17,495
-1,300
| -7% | -$131K |
|
716
Crocs
CROX
$6.36B
| $1.77M | 0.01% |
16,200
-100
| -0.6% | -$11.6K |
|
717
Prosperity Bancshares
PB
$8.97B
| $1.77M | 0.01% |
23,531
+2,600
| +12% | +$201K |
|
718
RLI Corp
RLI
$5.87B
| $1.77M | 0.01% |
21,460
+1,200
| +6% | +$99.6K |
|
719
Voya Financial
VOYA
$9.16B
| $1.77M | 0.01% |
25,700
+1,700
| +7% | +$133K |
|
720
Louisiana-Pacific
LPX
$5.18B
| $1.77M | 0.01% |
17,076
+2,900
| +20% | +$315K |
|
721
Terreno Realty
TRNO
$7.5B
| $1.76M | 0.01% |
29,830
+2,000
| +7% | +$123K |
|
722
Americold
COLD
$4.32B
| $1.75M | 0.01% |
81,700
+7,800
| +11% | +$189K |
|
723
GitLab
GTLB
$7.32B
| $1.75M | 0.01% |
31,000
+2,800
| +10% | +$163K |
|
724
Snap
SNAP
$8.96B
| $1.74M | 0.01% |
161,873
-25,534
| -14% | -$288K |
|
725
Lantheus
LNTH
$6.59B
| $1.74M | 0.01% |
19,400
-700
| -3% | -$68.2K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.